DanielCarlsonDO

PubMed

• 2 citations
  Teclistamab-cqyv: The First Bispecific T-Cell Engager Antibody for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma.
  Gwen Hua, Ryan Scanlan, Rachael Straining, Daniel S Carlson> ;Journal of the Advanced Practitioner in Oncology. 2023 Mar 1
• Tebentafusp-tebn: A Novel Bispecific T-Cell Engager for Metastatic Uveal Melanoma.
  Gwen Hua, Daniel Carlson, Jacqueline R Starr> ;Journal of the Advanced Practitioner in Oncology. 2022 Sep 1
• 3 citations
  The Effectiveness of Shared Compared to Informed Decision Making for Prostate Cancer Screening in a High-Risk African American Population: A Randomized Control Trial.
  Daniel S Carlson, Petros Grivas, Wei Wei, Puneet K Dhillon, Samir Abraksia> ;Cancer Investigation. 2021 Jan 7
• 5 citations
  Outcomes of Cardiovascular Surgery Utilizing Heparin versus Direct Thrombin Inhibitors in Cardiopulmonary Bypass in Patients with Previously Diagnosed HIT.
  Daniel S Carlson, John R. Bartholomew, Marcelo Gomes, Keith R. McCrae, Shruti Chaturvedi> ;Thrombosis and Haemostasis. 2020 Feb 1
• Join now to see all

Journal Articles

• Education and informed decision making for prostate cancer screening in a high risk African American community  
  Dhillon P.K., Grivas P., Hobbs B., Carlson D.S., Abraksia S., Integrative Clinical Medicine, 4/12/2019

Abstracts/Posters

• Evolving Data on CAR T-Cell Therapy for Multiple Myeloma, Novel Targets, Conditioning Regimens and Novel Constructs: A Systematic Review
  Yusra Shao, MD , Daniel S Carlson, DO , Faiz Anwer, MD, Blood, 11/13/2019
• Heparin vs Direct Thrombin Inhibitors in Patients with Previous HIT Undergoing Cardiothoracic Surgery: The Cleveland Clinic Experience
  Carlson, D.S., McCrae, K.R., Chaturvedi, S., Blood/American Society of Hematology, San Diego, CA, 12/2/2018

Lectures

• Heparin vs. Direct Thrombin Inhibitors in Patients with Previous HIT Undergoing Cardiothoracic Surgery: The Cleveland Clinic Experience 
  San Diego, CA - 12/2/2018